Valuation

ABTAbbott

StockNYSEUnited StatesHealth careEU retail investors: available

0.0% today · −10.1% over a year

6/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 63% of the instruments we score

Stability: among the best of its peers; priced lower than most peers. Dividend yield 2.82%.

Abbott (ABT) valuation against sector peers: P/E 40.7 (sector median 30.7), P/B 3.7, EV/EBIT 32.9, free-cash-flow yield 3.5%, P/S 4.0.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricABTSector medianvs median
P/E40.730.7 · n=15833% above
P/B3.74.0 · n=3076% below
P/S4.04.1 · n=302near the median
EV/EBIT32.925.8 · n=14628% above
Free-cash-flow yield3.5%1.4% · n=291150% above
Dividend yield2.82%0.00% · n=362—
Return on equity9.2%−2.4% · n=308—
Return on invested capital7.1%0.6% · n=282998% above
Gross margin56.9%63.3% · n=20510% below
Net debt / EBITDA2.541.27 · n=151101% above

Value factor: 70 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

LLYEli Lilly & Co48.933.5—1.5%0.6%6/10
JNJJohnson & Johnson42.08.3—3.0%1.9%8/10
ABBVAbbVie50.5—27.83.6%2.9%6/10
MRKMerck148.88.1—4.0%2.3%8/10
UNHUnitedHealth22.93.517.36.3%2.2%10/10
TMOThermo Fisher Scientific37.64.935.62.9%0.3%9/10
AMGNAmgen26.817.523.23.8%2.1%8/10
GILDGilead Sciences—16.3—6.5%1.9%5/10
PFEPfizer41.51.9—7.0%7.3%1/10
DHRDanaher38.43.135.83.4%0.6%7/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Sep 2026 · filed 04 Nov 2026